Hosted on MSN8mon
Tempus wins FDA nod for AI-backed heart diagnosticBased on recordings of 12-lead electrocardiogram (ECG) devices, the Tempus ECG-AF algorithm can detect the risk of a patient developing AF over the next 12 months. The company added that the ...
effective January 1, 2025. This ruling is expected to allow hospitals to receive reimbursement for using Tempus’ ECG-AF to help identify patients at increased risk of AF. Earlier this year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results